Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Coya Therapeutics Logo
Coya Therapeutics Growth Score
80
CB Rank
3530
Heat Score
63
Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases
Founded
obfuscation
PublicPost-IPO Equity Houston, Texas, United States1-10 coyatherapeutics.com/
Biopharma
Biotechnology
Life Science
Overview

Coya Therapeutics
Total Funding
obfuscation
Growth Score
80
Heat Score
63

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score80
4 pts
in past quarter
Heat Score 63
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Coya Therapeutics

CB Rank
3530
Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases
Founded
obfuscation
PublicPost-IPO Equity Houston, Texas, United States1-10 coyatherapeutics.com/
Biopharma
Biotechnology
Life Science

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Arun Swaminathan
    Arun Swaminathan: CBO
    Past Role: Lynkogen, CEO & Co-Founder
  • Photo of Adrian Hepner
    Adrian Hepner: Chief Medical Officer
    Past Role: Eagle Pharmaceuticals, Executive Vice President and Chief Medical Officer

Details

Legal Name Coya Therapeutics Inc.
Operating Status Active
Stock Symbol  NASDAQ:COYA
Company Type For Profit
Founders  Howard Berman, Howard Berman
About the Company
Coya Therapeutics is a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cells (Tregs) function in vivo, including allogeneic Treg-derived exosome therapeutics and novel biologics.
Phone Number 1(800) 587-8570
Contact Email daniel@coyatherapeutics.com
Predictions & Insights

Growth Insight

See this Growth Insight
Coya Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

COYA 302
A biologic combination therapy designed to enhance Treg function and decrease inflammation by targeting effector T cells and macrophages.
COYA 301
A Treg-enhancing biologic therapy aimed at reducing inflammation through the development, expansion, activity, and survival of Tregs.

Research & Development

Coya Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity
obfuscation
Post-IPO Equity - Coya Therapeutics Logo
Post-IPO Equity - Coya Therapeutics
2
obfuscation
Dr. Reddy’s LaboratoriesPost-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 6 Board Members and Advisors 1 Contacts 8

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,329
97.77%
 in past month

IT Spend

$267.2KThis year, Coya Therapeutics is projected to spend $267.2K on IT, according to Aberdeen.

Active Website Tech Count

15Coya Therapeutics is actively using 15 technologies for its website, according to BuiltWith. These include HSTS, DNSSEC, and  Content Delivery Network.

Total IP

8The intellectual property of Coya Therapeutics includes 8 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Coya Therapeutics's headquarters? Coya Therapeutics is located in Houston, Texas, United States.Who invested in Coya Therapeutics? Coya Therapeutics has 5 investors including Dr. Reddy’s Laboratories and  Greenlight Capital.When was the last funding round for Coya Therapeutics? Coya Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Coya Therapeutics raised to date? Coya Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|